Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 17 AUGUST 2026

A Five-Part Framework To Mitigate “Made In America” Scrutiny

Outside GC
Explore more from Outside GC

Billie Munro Audia and Jolene Russell present a comprehensive five-part framework designed to help in-house counsel strengthen sourcing agreements and ensure their company's "Made in USA" claims meet regulatory requirements. The framework provides practical guidance for navigating the complex landscape of origin labeling compliance and mitigating potential regulatory risks.

United StatesCorporate/Commercial Law
Billie Munro Audia
Billie Munro Audia
Author LinkedIn connections

In her latest Contracts Corner column for Corporate Counsel Now, powered by ACC, Billie Munro Audia, joined by co-author, Jolene Russell, Deputy General Counsel & Chief Compliance Officer for Shaw Industries Group, Inc., offers in-house counsel a five-part framework for tightening sourcing agreements so that a company’s “Made in USA” claims can withstand regulatory scrutiny.

Audia’s Contracts Corner column features advice and actionable tips designed to help in-house counsel navigate the increasingly complex world of commercial contracts.

Billie Munro Audia is a Partner with OGC. She is a former General Counsel in the technology sector. Billie advises clients in the technology, retail and medtech sectors on intellectual property and corporate matters.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte